FL Baehner

S4-6: A Quantitative Multigene RT-PCR Assay for Predicting Recurrence Risk after Surgical Excision Alone without Irradiation for Ductal Carcinoma In Situ (DCIS): A Prospective Validation Study of the DCIS Score from ECOG E5194.

L.J. Solin, Robert J. Gray, FL Baehner et al. · Cancer Research · 2011 · 36 citations

Surgical Oncology, Cancer Management, Pathology +20

Risk of distant recurrence using oncotype DX in postmenopausal primary breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.

Mitch Dowsett, J Cuzick, Craig Wales et al. · Cancer Research · 2009 · 35 citations

Surgical Oncology, Breast Oncology, Recurrence Score +22

Abstract S1-10: Association between the 21-gene recurrence score (RS) and benefit from adjuvant paclitaxel (Pac) in node-positive (N+), ER-positive breast cancer patients (pts): Results from NSABP B-28

EP Mamounas, Grace H. Tang, Seungmok Paik et al. · Cancer Research · 2012 · 23 citations

Breast Oncology, Distant Recurrence, Immunology +19

Abstract P5-15-01: Breast cancer specific survival in 38,568 patients with node negative hormone receptor positive invasive breast cancer and oncotype DX recurrence score results in the SEER database

S. Shak, VI Petkov, DP Miller et al. · Cancer Research · 2016 · 14 citations

Breast Oncology, Cancer Management, Seer Database +19

Abstract P3-10-01: Quantitative Gene Expression Analysis in a Large Cohort of Estrogen-Receptor Positive Breast Cancers: Characterization of the Tumor Profiles in Younger Patients (≥40 yrs) and in Older Patients (≥70 yrs)

S. Shak, FL Baehner, Mark Stein et al. · Cancer Research · 2010 · 11 citations

Breast Oncology, Younger Patients, Pathology +17